Login to Your Account



NewCo News: Beer Company Spinout ApoLife Launches Yeast-Based Pipeline

By Catherine Shaffer


Monday, October 10, 2011
ApoLife Inc. has joined the growing ranks of platform technology companies branching out into internal drug discovery and development. At a time when other small biotech companies are struggling to secure start-up financing, ApoLife already has a revenue stream from its yeast-based antibody production business.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription